Clinical Trial Update: ModraDoc006/r in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ModraDoc006/r in metastatic and recurrent breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ModraDoc006/r

Snippet

Sponsor: Modra Pharmaceuticals | Conditions: Metastatic Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED